Latest Posts

Génome Québec congratulates the team of Dr. François Rousseau from CHU de Québec-Université Laval research centre, for its work that led to the Québec government’s decision to improve the Québec trisomy prenatal screening program by implementing second-line non-invasive genomic testing. This test may reduce the number of amniocenteses performed in Québec by 90% in the…

Don’t miss this evening of thought-provoking discussions about genomics which will be held at the Canada Science and Technology Museum. An opportunity to hear speakers from academia and industry explore the science, ethics, and impacts of genomics in our lives. B.F. Francis Ouellette, our VP, Scientific Affairs, is among the speakers who will discuss  some…

A novel study by bioinformatics and plant-biology experts from McGill University and Université de Montréal was published in the journal Microbiome. Using advanced techniques for analyzing the simultaneous expression of genes from multiple organisms in an ecosystem, the scientists examined the roots of willows grown on a polluted site in suburban Montréal. Their research showed…

Genome Canada has partnered with the Canadian Institutes of Health Research (CIHR) to launch a funding opportunity to support a national Research Catalyst Network. This initiative aims to stimulate collaboration between basic and clinician scientists in functional studies of novel rare disease genes. This network will help maintain Canada’s leadership in this field, while encouraging…

Génome Québec congratulates Silvia Vidal from McGill University and Christopher Borchers from the Jewish General Hospital who are respectively co-project leaders of the Centre for Phenogenomics and the Proteomics Centre, both recipients of the Genome Canada’s Genomics Technology Platforms Competition. Prof. Vidal is responsible for the McGill Infection & Inflammation Core Québec platform, part of the Centre…

Génome Québec is pleased to announce that it concluded two partnerships agreements in genomics with the Commissariat à l’énergie atomique et aux énergies alternatives and with Genopole. These collaborations will foster precision medicine research, in particular with respect to some common diseases prevalent in Québec and in France. They will also support the development for…

Congratulations to the research teams of McGill University and Génome Québec Innovation Centre, of the Canadian Centre for Computational Genomic and of the Centre for Advanced Proteomic and Chemogenomic Analyses These centres will receive a total of 19,64 million dollars, a funding that will allow them to continue supporting the research community with high level…

The 2018 Award aims to recognise, encourage, promote and disseminate outstanding examples of best practices in personalised medicine. Individuals who have published scientific papers and/or developed best practice strategies in the field of PM between January 1st, 2016 and December 31st, 2017, from any of the ICPerMed partner countries, are eligible to apply. The deadline for…

The Ataxia of Charlevoix-Saguenay Foundation offers annual research fellowships to find a treatment for this rare disease.  This call for proposals aims to fund projects that will clearly advance the understanding of the disease and lead the way to the development of a treatment for ARSACS patients.    To read the full funding offer, click…

On this February 4, Génome Québec wishes to underline the paramount importance of research in the fight against this disease that claims 80,000 Canadians every year.  Since 2002, we have participated in the funding of 15 research projects on cancer. This represents an investment of $73M from Génome Québec and its partners. These researches have…